Adaphostin

CAS No. 241127-58-2

Adaphostin( NSC 680410 | 1-Adamantyl 4-((2,5-Dihydroxybenzyl)Amino)Benzoate )

Catalog No. M27602 CAS No. 241127-58-2

Adaphostin is a p210Bcr/Abl tyrosine kinase inhibitor with IC50 of 14 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 61 In Stock
10MG 92 In Stock
25MG 188 In Stock
50MG 305 In Stock
100MG 458 In Stock
200MG Get Quote In Stock
500MG 995 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Adaphostin
  • Note
    Research use only, not for human use.
  • Brief Description
    Adaphostin is a p210Bcr/Abl tyrosine kinase inhibitor with IC50 of 14 μM.
  • Description
    Adaphostin is a p210Bcr/Abl tyrosine kinase inhibitor with IC50 of 14 μM.(In Vitro):It also induces apoptosis in T-lymphoblastic human leukemia cell lines with IC50 ranging from 16.8 to 216.3 nM in vitro.(In Vivo):Adaphostin can damage both myeloid and lymphoid leukemia cells.
  • In Vitro
    Adaphostin down-regulates p210bcr/abl in K562 cells and inhibits granulocyte colony formation in chronic myelogenous leukemia (CML) specimens at lower concentrations without enhanced toxicity in normal progenitors.Adaphostin-induced p53 up-regulation, DNA strand breaks, and ROS production in ML-1 cells is inhibited by N-acetylcysteine (NAC).
  • In Vivo
    ——
  • Synonyms
    NSC 680410 | 1-Adamantyl 4-((2,5-Dihydroxybenzyl)Amino)Benzoate
  • Pathway
    Angiogenesis
  • Target
    Bcr-Abl
  • Recptor
    Cyclophilin J
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    241127-58-2
  • Formula Weight
    393.483
  • Molecular Formula
    C24H27NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (127.07 mM)
  • SMILES
    Oc1ccc(O)c(CNc2ccc(cc2)C(=O)OC23CC4CC(CC(C4)C2)C3)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhao X, et al. Cyclophilin J PPIase Inhibitors Derived from 2,3-Quinoxaline-6 Amine Exhibit Antitumor Activity. Front Pharmacol. 2018 Feb 21;9:126.
molnova catalog
related products
  • Asciminib

    Asciminib (ABL-001) is a potent and selective allosteric ABL1 inhibitor with IC50 of 0.25 nM in BCR–ABL1-transformed BaF3 cells.

  • CHMFL-ABL-121

    CHMFL-ABL-121 is a highly potent inhibitor of type II ABL kinase.

  • CHMFL-ABL-039

    CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: 7.9 nM and 27.9 nM) used in the research of chronic myeloid leukemia.